New research suggests that a cholesterol drug could help some women fight breast cancer. Inflammatory breast cancer, or IBC, is a particularly aggressive form of the disease that's likely to spread.
A new study found that women taking generic Zocor when they were going through radiation were more likely to survive IBC. Researchers believe the cholesterol drug makes tumors more sensitive to radiation therapy.
Principal investigator Wendy Woodward, M.D., Ph.D. said, "our data suggest that clinical trials combining simvastatin (Zocor) with radiation therapy for IBC patients should definitely be the next step."